Prostate Cancer Clinical Trial
Proton Boost in Prostate Cancer
Summary
This study uses photon radiation with a proton boost to treat prostate cancer. The purpose of this study is to determine if proton therapy as a boost following photon intensity modulated radiation therapy (IMRT) produces decreased toxicity as compared to conventional photon IMRT alone in the treatment of prostate cancer. Our secondary objective is to determine the effectiveness of this treatment regimen. Effectiveness will be determined by length of time to progression or recurrence of disease and overall survival. Patients on this study will be treated with a course of photon radiation therapy followed by a boost course of proton radiation.
Eligibility Criteria
Inclusion Criteria:
≥18 years of age
Diagnosis of low risk prostate cancer (T1c-T2a, Gleason 6, Prostate Specific Antigen (PSA) <10) -OR-
Diagnosis of intermediate risk prostate cancer (T1c-T2c, Gleason 7 and/or PSA 10- 20)
Life expectancy >10 yrs
Physically and mentally capable of signing the consent form of their own volition
Exclusion Criteria:
< 18 years of age
Diagnosis of high risk prostate cancer (T3 or higher, Gleason >7 and/or PSA >20)
Current or historical use of androgen deprivation therapy
Nodal positivity
Previous cancer excluding non-melanoma skin cancer
History of prostatectomy
History of brachytherapy for prostate cancer
Life expectancy <10 yrs
Physically or mentally incapable of signing the consent form of their own volition
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Cincinnati Ohio, 45267, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.